Sequencing of treatment in metastatic colorectal cancer: where to fit the target
about
Dual Inhibition of MEK and PI3K Pathway in KRAS and BRAF Mutated Colorectal CancersAngiogenesis-related protein expression in bevacizumab-treated metastatic colorectal cancer: NOTCH1 detrimental to overall survivalChemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancer: Results of a registry-based cohort analysis.Comparative Effectiveness of Up To Three Lines of Chemotherapy Treatment Plans for Metastatic Colorectal Cancer
P2860
Sequencing of treatment in metastatic colorectal cancer: where to fit the target
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sequencing of treatment in metastatic colorectal cancer: where to fit the target
@en
Sequencing of treatment in metastatic colorectal cancer: where to fit the target.
@nl
type
label
Sequencing of treatment in metastatic colorectal cancer: where to fit the target
@en
Sequencing of treatment in metastatic colorectal cancer: where to fit the target.
@nl
prefLabel
Sequencing of treatment in metastatic colorectal cancer: where to fit the target
@en
Sequencing of treatment in metastatic colorectal cancer: where to fit the target.
@nl
P2860
P356
P1476
Sequencing of treatment in metastatic colorectal cancer: where to fit the target
@en
P2093
Ali Shamseddine
Deborah Mukherji
P2860
P304
P356
10.3748/WJG.V20.I8.1993
P407
P50
P577
2014-02-01T00:00:00Z